Where To Invest 10,000 Php

POLIO - Eradication

Polio is caused by three types of polio-virus (1,2,3), a microorganism belonging to the genus enterovirus, which invades the nervous system within a few hours, destroying the cells neural affected and causing a paralysis that can become, in severe cases, total. In about 95% of people infected by the polio virus does not occur any interference. Minor symptoms may include sore throat, low grade fever, nausea and vomiting. In some cases (1-2%) may occur stiffness of neck, back or legs, but without paralysis. Instead, in less than 1% of cases (approximately one in every 1,000 infections) occurs paralysis. In general, polio was the most devastating effects on the muscles of the legs than on the arms. The legs lose muscle tone and become flaccid, a condition known as flaccid paralysis. In cases of infection extended to all the arts, the patient may become quadriplegic. In the most severe form, the bulbar, the virus paralyzes the muscles innervated by cranial nerves, reducing breathing capacity, of ingestion and speech. In this case, you must support the patient with aids in breathing. The infection occurs via fecal-oral route through ingestion of contaminated food or water or by saliva droplets emitted by coughing and sneezing by individuals who are ill or healthy carriers. Described for the first time since Michael Underwood, a British physician, in 1789, polio was recorded for the first time in an epidemic form of early nineteenth century and soon after the United States. The spread of polio peaked in the United States in 1952 with over 21 thousand registered cases. In Italy, in 1958, over 8 thousand cases were reported. The last U.S. case dates back to 1979, while in our country was notified in 1982. http://www.polioeradication.org/ site presents the framework, updated daily, new cases of polio worldwide. The polio-virus infection, therefore, is not yet definitively eradicated disease: This guide identifies Nigeria and India as the countries most affected:

Total cases: Year-to-date 2009

Globally: 110

- in endemic countries: 80

- in non-endemic countries: 30

Country: Year-to-date2009

India: 17
Nigeria: 51
Uganda: 3
Pakistan: 8
Kenya: 2
Sudan: 11
Afghanistan: 4
Togo: 3
Benin: Burkina Faso 2
: 4
Angola: 1
Niger: 3
Mali: 1
CAR: 0
Chad: 0
Côte d'Ivoire:
Ghana 0: 0 DRC
: 0
Nepal: 0
Ethiopia: 0